EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond Targeted Newborn Screening: A Nontargeted Metabolomics Workflow to Investigate Birthweight–Metabolome Correlations

Carter K Asef iD, Samuel G Moore, Charles Austin Pickens, Carlos A Saavedra-Matiz, Joseph J Orsini, Konstantinos Petritis iD, David A Gaul iD, Facundo M Fernández iD

Analytical Chemistry · 01.04.2025 · 97 (12) · 6563-6570

DOI: 10.1021/acs.analchem.4c06061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 18.03.2025. Verfasst von Carter K Asef und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States. Hauptthemen laut MEDLINE: Metabolomics, Neonatal Screening, Birth Weight, Metabolome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening (NBS) is one of the United States' largest, most successful preventative public health initiatives, improving outcomes for newborns with inborn errors of metabolism. Most disorders on the Recommended Uniform Screening Panel are screened using triple-quadrupole mass spectrometry and flow injection analysis. While these methods are sensitive and well suited for high-throughput quantitative applications, the breadth of measured analytes is limited to a relatively small number of biomarkers, which often have considerable overlaps between healthy and diseased populations. High-resolution liquid chromatography-mass spectrometry (LC-MS)-based metabolomics is now capable of profiling thousands of metabolites, making it well suited for exploratory and biomarker discovery studies. To this end, we developed a robust workflow for performing nontargeted LC-MS analysis on dried bloodspot (DBS) specimens with coverage across many metabolic pathways relevant to NBS. HILIC chromatography enabled quantitation of amino acid and acylcarnitine species while also retaining lipid species, such as lyso-phosphatidylcholines. We analyzed 810 newborn-derived DBS samples across a wide range of newborn birthweights, identifying correlations with metabolites that help to better account for the lower accuracy observed for some NBS markers (e.g., isovalerylcarnitine). Additionally, we leveraged this nontargeted workflow to capture new biomarkers and metabolic phenotypes in newborns associated with parenteral nutrition administration and maternal nicotine exposure. Two critical biomarkers were identified as useful additions to targeted screening panels: N-acetyltyrosine as a qualitative marker for parenteral nutrition administration and N-acetylputrescine as a quantitative marker for controlling birthweight variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsNeonatal ScreeningBirth WeightMetabolomeInfant, NewbornHumansDried Blood Spot TestingChromatography, LiquidWorkflowBiomarkersMass SpectrometryCarnitine

Substanzen

BiomarkersCarnitine

Autor:innen und Institutionen

  • School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
  • Petit Institute of Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
  • Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, United States.
  • Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, New York 12237, United States.

ORCID-Profile: Carter K Asef, Konstantinos Petritis, David A Gaul, Facundo M Fernández

Zitieren

APA

Asef, C. K., Moore, S. G., Pickens, C. A., Saavedra-Matiz, C. A., Orsini, J. J., Petritis, K., Gaul, D. A., & Fernández, F. M. (2025). Beyond Targeted Newborn Screening: A Nontargeted Metabolomics Workflow to Investigate Birthweight–Metabolome Correlations. Analytical Chemistry, 97(12), 6563-6570. https://doi.org/10.1021/acs.analchem.4c06061

Vancouver

Asef CK, Moore SG, Pickens CA, Saavedra-Matiz CA, Orsini JJ, Petritis K, et al. Beyond Targeted Newborn Screening: A Nontargeted Metabolomics Workflow to Investigate Birthweight–Metabolome Correlations. Analytical Chemistry. 2025;97(12):6563-6570. doi:10.1021/acs.analchem.4c06061

BibTeX
@article{Asef2025,
  author = {Asef, Carter K and Moore, Samuel G and Pickens, Charles Austin and Saavedra-Matiz, Carlos A and Orsini, Joseph J and Petritis, Konstantinos and Gaul, David A and Fernández, Facundo M},
  title = {Beyond Targeted Newborn Screening: A Nontargeted Metabolomics Workflow to Investigate Birthweight–Metabolome Correlations},
  journal = {Analytical Chemistry},
  year = {2025},
  volume = {97},
  number = {12},
  pages = {6563--6570},
  doi = {10.1021/acs.analchem.4c06061}
}
Kostenlos starten →